Woman Man
- | Country :
- Mexico
- Croatia
- Poland
- The 12 others...
- | organs : -
- | Specialty : -
Extract
Primary: To assess the efficacy and safety of DVS-233 SR compared with placebo for treatment of vasomotor symptoms (VMS) associated with menopause and to compare the bleeding incidence of DVS-233 SR and tibolone. Secondary: To assess the effects of DVS-233 SR and tibolone on changes from baseline in weight, breast pain, and health outcomes indicators.
Inclusion criteria
- Menopause